Evidence map›Paper›PMID 31432258›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2019

Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.

Eleonora Fiorenzato, Angelo Antonini, Valeria Camparini, Luca Weis, Carlo Semenza, Roberta Biundo

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Attention/Working Memory and Executive Function in Parkinson's Disease: Review, Critique, and Recommendations.Movement disorders : official journal of the Movement Disorder Society · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Pathomechanisms of cognitive impairment in progressive supranuclear palsy.Journal of neural transmission (Vienna, Austria : 1996) · 2023
    Review
  19. Article
  20. Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes.Journal of neural transmission (Vienna, Austria : 1996) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Eleonora FiorenzatoIRCCS San Camillo Hospital, Via Alberoni, 70, 30126, Venice, Italy. eleonora.fiorenzato@gmail.com.ORCID 0000-0001-7947-5903
Angelo AntoniniDepartment of Neurosciences, Padova Neuroscience Center, University of Padua, Via Giustiniani, 5, 35128, Padua, Italy.
Valeria CampariniIRCCS San Camillo Hospital, Via Alberoni, 70, 30126, Venice, Italy.
Luca WeisIRCCS San Camillo Hospital, Via Alberoni, 70, 30126, Venice, Italy.
Carlo SemenzaIRCCS San Camillo Hospital, Via Alberoni, 70, 30126, Venice, Italy.
Roberta BiundoIRCCS San Camillo Hospital, Via Alberoni, 70, 30126, Venice, Italy.
IRCCS San Camillo Hospital · ITUniversity of Padua · IT

Funding

Ministero della Salute GR-2016-02361986
6 · The paper itself

Abstract

Cognitive impairment is frequent in progressive supranuclear palsy (PSP) and less common in multiple system atrophy (MSA), but characteristics and progression compared with Parkinson's disease (PD) need to be properly defined. We evaluated 35 PSP with Richardson's syndrome (PSP-RS), 30 MSA as well as 65 age-, sex-, and education-matched PD with an extensive clinical and neuropsychological assessment, allowing Level II cognitive diagnosis. Eighteen PSP, 12 MSA and 30 PD had a second evaluation between 12 and 18 months (mean 15 months) after the first assessment. PSP performance at Montreal Cognitive Assessment (MoCA), verbal fluencies (phonemic and semantic tasks), Stroop test (Error and Time), Digit Span Sequencing (DSS), incomplete letters of Visual Object and Space Perception (VOSP) and Benton's Judgment of Line Orientation (JLO) performance were significantly poorer at baseline compared to PD and MSA. Executive, language and visuospatial abilities declined longitudinally in PSP, but not in PD and MSA. After 1.5 year, 16% of PSP converted to dementia. Our study provides evidence that cognitive progression is more severe and rapid in PSP-RS than PD and MSA. Further, we observed that MoCA, verbal fluency (particularly semantic), DSS and Benton's JLO are valuable tests to detect cognitive progression in PSP-RS and may be proposed as possible biomarker to assess efficacy of disease modification strategies.

Indexed as

Disease ProgressionAgedCognitive DysfunctionDementiaFemaleHumansLongitudinal StudiesMaleMiddle AgedMultiple System AtrophyParkinson DiseaseSupranuclear Palsy, ProgressiveExecutive functionsLongitudinal studyParkinson’s diseaseProgressive supranuclear palsyVerbal fluencyVisuospatial functions

Identifiers

PMID31432258
OpenAlexW2969645949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.